Long-Term Continuous Corticosterone Treatment Decreases VEGF Receptor-2 Expression in Frontal Cortex
2011

Corticosterone Treatment Reduces Flk1 Expression in the Brain

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Howell Kristy R., Kutiyanawalla Ammar, Pillai Anilkumar

Primary Institution: Georgia Health Sciences University

Hypothesis

Long-term continuous glucocorticoid exposure affects VEGF/Flk1 signaling in the brain.

Conclusion

Chronic corticosterone treatment decreases Flk1 protein levels in the frontal cortex, which may contribute to the neurobiological effects of chronic stress.

Supporting Evidence

  • Long-term corticosterone treatment reduced Flk1 protein levels in both cultured neurons and mouse frontal cortex.
  • VEGF levels increased in the cortex but decreased in serum following corticosterone treatment.
  • Significant reductions in Flk1 and GR protein levels were found in postmortem prefrontal cortex samples from schizophrenia subjects.

Takeaway

Giving mice a hormone called corticosterone for a long time makes a brain protein called Flk1 go down, which might be important for understanding stress effects on the brain.

Methodology

The study involved in vitro and in vivo experiments examining the effects of corticosterone on Flk1 signaling in cultured neurons and mouse brain tissue.

Potential Biases

Potential confounding factors related to postmortem sample collection and analysis.

Limitations

The study's sample size for human subjects was small and demographic variables were not well matched.

Participant Demographics

The study included postmortem samples from schizophrenia subjects and control subjects, with no significant differences in age, gender, or other confounding variables.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0020198

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication